참고문헌
- Jemal A, Bray F, Center MM, et al (2011). CA Cancer J Clin, 61, 69-90. https://doi.org/10.3322/caac.20107
- Maluccio M, Covey A (2012). Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin, 62, 394-9. https://doi.org/10.3322/caac.21161
- Bruix J, Gores GJ, Mazzaferro V (2014). Hepatocellular carcinoma: clinical frontiers and perspectives. Gut, 63, 844-55. https://doi.org/10.1136/gutjnl-2013-306627
- Zuo CH, Xia M, Liu JS, et al (2015). Transcatheter arterial chemoembolization combined with interferon-alpha is safe and effective for patients with hepatocellular carcinoma after curative resection. Asian Pac J Cancer Prev, 16, 245-51. https://doi.org/10.7314/APJCP.2015.16.1.245
- Bruix J, Sherman M (2011). Management of hepatocellular carcinoma: an update. Hepatol, 53, 1020-2. https://doi.org/10.1002/hep.24199
- Xu C, Lv PH, Huang XE, et al (2014). Safety and efficacy of sequential transcatheter arterial chemoembolization and portal vein embolization prior to major hepatectomy for patients with HCC. Asian Pac J Cancer Prev, 15, 703-6. https://doi.org/10.7314/APJCP.2014.15.2.703
- Marrero JA, Fontana RJ, Barrat A, et al (2005). Prognosis of hepatocellular carcinoma: comparison of 7 staging systems in an American cohort. Hepatol, 41, 707-16. https://doi.org/10.1002/hep.20636
- Zhong JH, Ke Y, Gong WF, et al (2014). Hepatic resection associated with good survival for selected patients with intermediate and advanced-stage hepatocellular carcinoma. Ann Surg, 260, 329-40. https://doi.org/10.1097/SLA.0000000000000236
- Jianyong L, Lunan Y, Wentao W, et al (2014). Barcelona clinic liver cancer stage B hepatocellular carcinoma: transarterial chemoembolization or hepatic resection? Medicine (Baltimore), 93, 180. https://doi.org/10.1097/MD.0000000000000180
- Slevin ML (1992). Quality of life: philosophical question or clinical reality? BMJ, 305, 466-9. https://doi.org/10.1136/bmj.305.6851.466
- Han KT, Park EC, Kim SJ, et al (2014). Factors affecting the quality of life of Korean cancer survivors who return to the workplace. Asian Pac J Cancer Prev, 15, 8783-8. https://doi.org/10.7314/APJCP.2014.15.20.8783
- Langenhoff BS, Krabbe PF, Wobbes T, et al (2001). Quality of life as an outcome measure in surgical oncology. Br J Surg, 88, 643-52. https://doi.org/10.1046/j.1365-2168.2001.01755.x
- Scurtu R, Groza N, Otel O, et al (2005). Quality of life in patients with esophagojejunal anastomosis after total gastrectomy for cancer. Rom J Gastroenterol, 14, 367-72.
- Diouf M, Bonnetain F, Barbare JC, et al (2015). Optimal cut points for quality of life questionnaire-core 30 (QLQ-C30) scales: utility for clinical trials and updates of prognostic systems in advanced hepatocellular carcinoma. Oncologist, 20, 62-71. https://doi.org/10.1634/theoncologist.2014-0175
- Diouf M, Filleron T, Barbare JC, et al (2013). The added value of quality of life (QoL) for prognosis of overall survival in patients with palliative hepatocellular carcinoma. J Hepatol, 58, 509-21. https://doi.org/10.1016/j.jhep.2012.11.019
- Yeo W, Mo FK, Koh J, et al (2006). Quality of life is predictive of survival in patients with unresectable hepatocellular carcinoma. Ann Oncol, 17, 1083-9. https://doi.org/10.1093/annonc/mdl065
- Gandhi S, Khubchandani S, Iyer R (2014). Quality of life and hepatocellular carcinoma. J Gastrointest Oncol, 5, 296-317.
- Fan SY, Eiser C, Ho MC (2010). Health-related quality of life in patients with hepatocellular carcinoma: a systematic review. Clin Gastroenterol Hepatol, 8, 559-64. https://doi.org/10.1016/j.cgh.2010.03.008
- Bruns H, Kratschmer K, Hinz U, et al (2010). Quality of life after curative liver resection: a single center analysis. World J Gastroenterol, 16, 2388-95. https://doi.org/10.3748/wjg.v16.i19.2388
- Mise Y, Satou S, Ishizawa T, et al (2014). Impact of surgery on quality of life in patients with hepatocellular carcinoma. World J Surg, 38, 958-67. https://doi.org/10.1007/s00268-013-2342-9
- Xing M, Webber G, Prajapati HJ, et al (2015). Preservation of quality of life with doxorubicin drug eluting bead transarterial chemoembolization for unresectable hepatocellular carcinoma: longitudinal prospective study. J Gastroenterol Hepatol, [Epub ahead of print].
- Wang YB, Chen MH, Yan K, et al (2007). Quality of life after radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma: comparison with transcatheter arterial chemoembolization alone. Qual Life Res, 16, 389-97. https://doi.org/10.1007/s11136-006-9133-9
- Toro A, Pulvirenti E, Palermo F, et al (2012). Health-related quality of life in patients with hepatocellular carcinoma after hepatic resection, transcatheter arterial chemoembolization, radiofrequency ablation or no treatment. Surg Oncol, 21, 23-30. https://doi.org/10.1016/j.suronc.2010.07.008
- Li L, Wang H, Shen Y (2002). Development and psychometric tests of a Chinese version of the SF-36 Health Survey Scales. Zhonghua yu fang yi xue za zhi, 36, 109-13.
- Jin S, Yan L, Li B, et al (2010). Quality of life and psychologic distress of recipients after adult living-donor liver transplantation (LDLT)-A study from mainland China. Transplant Proc, 42, 2611-6. https://doi.org/10.1016/j.transproceed.2010.04.062
- Zhang T, Zeng Y, Huang J, et al (2014). Combined resection with radiofrequency ablation for bilobar hepatocellular carcinoma: a single-center experience. J Surg Res, 191, 370-8. https://doi.org/10.1016/j.jss.2014.03.048
- Jiang L, Lei JY, Wang WT, et al (2014). Immediate radical therapy or conservative treatments when meeting the Milan criteria for advanced HCC patients after successful TACE. J Gastrointest Surg, 18, 1125-30. https://doi.org/10.1007/s11605-014-2508-2
- Mancuso A, Mazzola A, Cabibbo G, et al (2015). Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis. Dig Liver Dis, 47, 324-30 https://doi.org/10.1016/j.dld.2015.01.001
- Berk V, Kaplan MA, Tonyali O, et al (2013). Efficiency and side effects of sorafenib therapy for advanced hepatocellular carcinoma: a retrospective study by the anatolian society of medical oncology. Asian Pac J Cancer Prev, 14, 7367-9. https://doi.org/10.7314/APJCP.2013.14.12.7367
- Schipper H, Clinch J, McMurray A, et al (1984). Measuring the quality of life of cancer patients: the functional living indexcancer: development and validation. J Clin Oncol, 2, 472-83. https://doi.org/10.1200/JCO.1984.2.5.472
- Steel JL, Geller DA, Robinson TL, et al (2014). Health-related quality of life as a prognostic factor in patients with advanced cancer. Cancer, 120, 3717-21. https://doi.org/10.1002/cncr.28902
- Martin RC, Eid S, Scoggins CR, et al (2007). Health-related quality of life: return to baseline after major and minor liver resection. Surgery, 142, 676-84. https://doi.org/10.1016/j.surg.2007.04.026
- Poon RT, Fan ST, Yu WC, et al (2001). A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma. Arch Surg, 136, 693-9. https://doi.org/10.1001/archsurg.136.6.693
피인용 문헌
- Transarterial Therapies for Hepatocellular Carcinoma: a Comprehensive Review with Current Updates and Future Directions vol.17, pp.2, 2016, https://doi.org/10.7314/APJCP.2016.17.2.473
- Health-Related Quality of Life in Patients with Hepatocellular Carcinoma Treated with Initial Transarterial Chemoembolization vol.40, pp.10, 2017, https://doi.org/10.1007/s00270-017-1681-6